Neuren Pharmaceuticals

Neuren Pharmaceuticals is one of the...

• Russell 3000;
• S&P/ASX200.

Neuren Pharmaceuticals is a company listed under the stock ticker NEU (AU).

View the org chart displaying its 16 main executives

Most searched biographies at Neuren Pharmaceuticals

• Jon Pilcher, Chief Executive Officer and Director
• Jenny Harry, Non-Executive Director
• Dianne Angus, Non-Executive Director

Create your alert
to follow the executive moves at Neuren Pharmaceuticals.

Neuren Pharmaceuticals has 2,282 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
• Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
• Histogen has filed for bankruptcy protection  (posted on April 19 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion
• Vik Bajaj - Director at Interline Therapeutics

Learn more about the Biotechnology industry >

Press releases by Neuren Pharmaceuticals

• News & Reports | Neuren Pharmaceuticals

Social media about Neuren Pharmaceuticals

• Neuren Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
• Neuren Pharmaceuticals on LinkedIn, Twitter & YouTube

Contact by email its executives including Jon Pilcher

Call Neuren Pharmaceuticals at +61 39...

View the org chart

Register to receive your alert

Report an error